Companies: 10,795·Total market cap: $144.5T
Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc.

ESPRNASDAQHealthcare● Active
$3.14
+$0.01(+0.32%)
Market Cap$652833378
P/E Ratio
52W High$4.18
52W Low$0.95

Esperion Therapeutics, Inc. (ESPR) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ESPR · as of Mar 10, 2026

Latest filing snapshot

294
-10-3.29%vs prior year

Esperion Therapeutics, Inc. (ESPR) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
294
Change (1Y)
-10
Growth % (1Y)
-3.29%
Revenue / Employee
$1.37M
Net Income / Employee
$-77.2K
Market Cap
$655M

ESPR Employee Count

2013 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-10294-10-3.29%
2025-03-07304+64+26.67%
2024-02-27240+41+20.60%
2023-02-21199-19-8.72%
2022-02-22218-261-54.49%
2021-02-23479+286+148.19%
2020-02-27193+117+153.95%
2019-02-2876+19+33.33%
2018-02-2057+13+29.55%
2017-02-2244+12+37.50%

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Orthofix Medical Inc.
OFIX
Orthofix Medical Inc.
1,616
#2
Emergent BioSolutions Inc.
EBS
Emergent BioSolutions Inc.
900
#3
Esperion Therapeutics, Inc.
ESPR
Esperion Therapeutics, Inc.YOU
294
#4
Absci Corporation
ABSI
Absci Corporation
156
#5
Aquestive Therapeutics, Inc.
AQST
Aquestive Therapeutics, Inc.
142
#6
Olema Pharmaceuticals, Inc.
OLMA
Olema Pharmaceuticals, Inc.
96
#7
Corvus Pharmaceuticals, Inc.
CRVS
Corvus Pharmaceuticals, Inc.
31
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ESPR peer comparison

About ESPR employees

ESPR Employees · Headcount

Esperion Therapeutics, Inc. (ESPR) employee data is sourced from the annual SEC 10-K filing. As of 2025, Esperion Therapeutics, Inc. had 294 full-time employees globally. Full-time employees only. Global consolidated headcount.

Esperion Therapeutics, Inc. employs 294 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1.37M, reflecting the company's operational efficiency.

Esperion Therapeutics, Inc.'s workforce decreased by 10 (3.29%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Esperion Therapeutics, Inc.'s revenue per employee of $1.37M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

ESPR Employees · 5 questions

As of the latest SEC 10-K filing (2025), Esperion Therapeutics, Inc. had 294 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Esperion Therapeutics, Inc. employee counthow many employees does Esperion Therapeutics, Inc. haveESPR total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-10